•Abivax CEO told CNBC that the $920 million cash haul enables the company to launch its bowel disease drug in the U.S. independently without a Big Pharma partner.
•Raiffeisen Bank International's shared service center adopted Broadridge's BRx Match platform to enhance operational efficiency across Europe and Asia.
•Portuguese energy firm Galp has filed an arbitration case against Mozambique at the International Centre for Settlement of Investment Disputes (ICSID).
•Jiuzi Holdings announced its intention to sign a cooperation agreement with a company specializing in AI intelligent imaging and data platform technologies.
